Jagsonpal Pharmaceuticals informs about updates

07 Oct 2025 Evaluate
Jagsonpal Pharmaceuticals has informed that consequent to the appointment of Nirav Niranjankumar Vora as Chief Financial Officer, the Board of Directors have approved changes in KMPs authorized for the purpose of determining the materiality of an event or information and for the purpose of making disclosures to stock exchange(s) under the SEBI (LODR). The contact details of the KMPs authorized are as enclosed.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

209.40 -8.75 (-4.01%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×